QuantLogix ← ZBH scorecard
📅 ZBH Earnings Preview
Zimmer Biomet Holdings, Inc.
Next report (est.)
September 15, 2026
Countdown
94 days
EPS growth YoY
+34.1%
Revenue growth YoY
+9.3%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
May 1, 2026 ±5.4% +0.6% over-priced
November 5, 2025 ±2.7% -15.2% under-priced
August 7, 2025 ±2.2% +8.0% under-priced
May 5, 2025 ±1.9% -11.6% under-priced
October 30, 2024 ±1.6% +5.7% under-priced
August 7, 2024 ±3.1% -3.4% under-priced
May 2, 2024 ±2.0% -0.9% over-priced
November 7, 2023 ±2.6% -3.1% under-priced
Across these reports, options implied an average ±2.7% move vs an actual average of 6.1% — the stock stayed inside the implied band 25% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q1 FY2026 $1.22 $2.1B $238M
Q4 FY2025 $0.71 $2.2B $138M
Q3 FY2025 $1.16 $2.0B $231M
Q2 FY2025 $0.77 $2.1B $153M
Analyst posture
Buy / Strong Buy
12
Hold
20
Sell
2
Stable: +3 net change 30d
Live 5-factor engine read: Buy · 54/100 Full scorecard →
Get alerted before every ZBH report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on ZBH before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Zimmer Biomet Holdings, Inc. (ZBH) reports in 94 days, with the next report estimated for September 15, 2026. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 6.1% on average — the market has tended to under-price ZBH's earnings risk. Fundamentals into the print: EPS up 34.1% year-over-year, revenue up 9.3%. QuantLogix's live 5-factor engine currently reads ZBH as a buy at 54/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →